Celularity Inc (CELU) stock news · rev $26.6M
Celularity Inc (CELU) is a biotechnology company listed on US.
This CELU news page leads with what Celularity Inc filed — not a scraped headline mill.
No cached 8-K sentence for CELU yet. We will not pad this page with generic market recap.
Latest reported CELU revenue for 2025-12-31 was $26.6M. Net income was -$91.7M. Revenue was down 51.0% from 2024-12-31 to 2025-12-31. CELU currently screens at market cap $25.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CELU stock page; for the tape open the quote page.
Not investment advice.